2-piperidone has been researched along with Small Cell Lung Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergqvist, M; Bergström, S; Ekman, S; Gullbo, J; Lennartsson, J; Sooman, L | 1 |
Danishefsky, SJ; Downey, R; Lecomte, N; Moore, MA; Nagorny, P; Njardarson, JT; Ouerfelli, O; Yang, G | 1 |
2 other study(ies) available for 2-piperidone and Small Cell Lung Carcinoma
Article | Year |
---|---|
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Bortezomib; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Gefitinib; Gemcitabine; Humans; Piperidones; Proteasome Inhibitors; Quinazolines; Small Cell Lung Carcinoma; Vinblastine; Vinorelbine | 2017 |
Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin.
Topics: Animals; Cell Line, Tumor; Cell Movement; Ethers; Humans; Lung Neoplasms; Macrolides; Male; Mice; Neoplasm Metastasis; Piperidones; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2011 |